These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 8985281

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects.
    Fuda F, Narayan SB, Squires RH, Bennett MJ.
    Clin Chim Acta; 2006 May; 367(1-2):185-8. PubMed ID: 16414039
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Decreased carnitine biosynthesis in rats with secondary biliary cirrhosis.
    Krähenbühl S, Brass EP, Hoppel CL.
    Hepatology; 2000 Jun; 31(6):1217-23. PubMed ID: 10827145
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Caffeine elimination in cirrhotic and non-cirrhotic liver disease of different etiology.
    Joeres R, Brachtel D, Gallenkamp H, Hofstetter G, Klinker H, Zilly W, Richter E.
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():56-61. PubMed ID: 7483716
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hepatic copper content, urinary copper excretion, and serum ceruloplasmin in liver disease.
    Ritland S, Steinnes E, Skrede S.
    Scand J Gastroenterol; 1977 Feb; 12(1):81-8. PubMed ID: 834974
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of GB virus-C/hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's disease.
    Tagger A, Ribero ML, Larghi A, Donato F, Zuin M, Chiesa R, Benetti G, Ramella G, Borzio M, Podda M.
    Am J Gastroenterol; 1999 Feb; 94(2):484-8. PubMed ID: 10022651
    [Abstract] [Full Text] [Related]

  • 11. Abnormal concentrations of esterified carnitine in bile: a feature of pediatric acute liver failure with poor prognosis.
    Shneider BL, Rinaldo P, Emre S, Bucuvalas J, Squires R, Narkewicz M, Gondolesi G, Magid M, Morotti R, Hynan LS.
    Hepatology; 2005 Apr; 41(4):717-21. PubMed ID: 15791615
    [Abstract] [Full Text] [Related]

  • 12. The influence of kidney transplantation on carnitine metabolism.
    Kohse KP, Dech E, Rössle C, Franz HE, Fürst P.
    Clin Nephrol; 1988 Apr; 29(4):199-205. PubMed ID: 3284670
    [Abstract] [Full Text] [Related]

  • 13. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases.
    Wu TT, Levy M, Correa AM, Rosen CB, Abraham SC.
    Cancer; 2009 Oct 01; 115(19):4564-75. PubMed ID: 19670455
    [Abstract] [Full Text] [Related]

  • 14. Complement metabolism in chronic liver disease: catabolism of C1q in chronic active liver disease and primary biliary cirrhosis.
    Potter BJ, Elias E, Thomas HC, Sherlock S.
    Gastroenterology; 1980 May 01; 78(5 Pt 1):1034-40. PubMed ID: 7380176
    [Abstract] [Full Text] [Related]

  • 15. [L-carnitine: metabolism, functions and value in pathology].
    Jacob C, Belleville F.
    Pathol Biol (Paris); 1992 Nov 01; 40(9):910-9. PubMed ID: 1296165
    [Abstract] [Full Text] [Related]

  • 16. Carnitine deficiency disorders in children.
    Stanley CA.
    Ann N Y Acad Sci; 2004 Nov 01; 1033():42-51. PubMed ID: 15591002
    [Abstract] [Full Text] [Related]

  • 17. Use of liver function tests as predictors of rifampicin metabolism in cirrhosis.
    McConnell JB, Powell-Jackson PR, Davis M, Williams R.
    Q J Med; 1981 Nov 01; 50(197):77-82. PubMed ID: 7267969
    [Abstract] [Full Text] [Related]

  • 18. Tissue inhibitors of metalloproteinases in liver and serum/plasma in chronic active hepatitis C and HCV-induced cirrhosis.
    Böker KH, Pehle B, Steinmetz C, Breitenstein K, Bahr M, Lichtinghagen R.
    Hepatogastroenterology; 2000 Nov 01; 47(33):812-9. PubMed ID: 10919037
    [Abstract] [Full Text] [Related]

  • 19. Hypercatabolism of the third component of complement in patients with primary biliary cirrhosis.
    Potter BJ, Elias E, Jones EA.
    J Lab Clin Med; 1976 Sep 01; 88(3):427-39. PubMed ID: 956695
    [Abstract] [Full Text] [Related]

  • 20. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.
    Tietge UJ, Selberg O, Kreter A, Bahr MJ, Pirlich M, Burchert W, Müller MJ, Manns MP, Böker KH.
    Liver Transpl; 2004 Aug 01; 10(8):1030-40. PubMed ID: 15390330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.